Physician profile
Wayne Charles Chen
NPI 1922269349
$1,958.52
in general payments reported to CMS, 2019-2025
18 companies · $428 in 2025
The $428 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $115 · 2021: $192 · 2022: $206 · 2023: $336 · 2024: $306 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $369.54 | 2019-2025 | Penmenvy, Bexsero, Pediarix |
| Ironshore Pharmaceuticals INC. | $279.90 | 2019-2024 | |
| Corium, LLC | $245.83 | 2022-2024 | Azstarys |
| Pfizer INC. | $243.68 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $165.73 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $127.63 | 2021-2025 | Gardasil 9, Vaxneuvance, Varivax |
| Ars Pharmaceuticals Operations, INC. | $124.74 | 2025 | Neffy |
| Sanofi Pasteur INC. | $89.09 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $50.68 | 2024-2025 | Zoryve |
| Neurelis, INC. | $41.94 | 2023 | Valtoco |
| Alk-Abello, INC | $37.44 | 2025 | Neffy |
| Genentech USA, INC. | $34.48 | 2020-2021 | |
| Seqirus USA INC | $33.63 | 2021-2023 | Flucelvax Quadrivalent |
| Tris Pharma INC | $29.06 | 2021 | |
| Cranial Technologies, INC | $25.63 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $23.65 | 2025 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $21.87 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.